Live feed07:30:11·972dSECFilingvia QuantisnowBrainstorm Cell Therapeutics Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update, Regulation FD Disclosure, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.BCLI· Brainstorm Cell Therapeutics Inc.Health CareOriginal source
